Light Touch Technology

Founded in 2017 and based in Osaka, Japan, Light Touch Technology Inc. , d. b. a.

Light Touch Technology, operates as a company that provides development of blood glucose sensors enabling measurement without blood sampling and offers manufacturing services data transmission to devices and support for clinical testing and production processes regulatory approval and product commercialization. In May 2026, Light Touch Technology raised an undisclosed amount of series B funding from JMTC Capital, Hiroshima Venture Capital, Capital, and Tamron. Light Touch Technology Inc. operates by revolutionizing diabetes management with its proprietary non-invasive blood glucose sensor, which utilizes advanced laser technology.

This innovative product alleviates the need for traditional blood sampling methods, targeting diabetic patients and healthcare providers. The technology aims to provide accurate glucose readings in home healthcare and wearable device markets, focusing on improving health outcomes across North America, Europe, and Asia. The revenue for Light Touch Technology Inc. is generated through the sale of its non-invasive blood glucose sensors and related devices, targeting both consumers and healthcare institutions.

The company employs a transactional model that includes direct sales and potential partnerships, facilitating market penetration and accessibility in the healthcare sector. As of May 2026, the company plans to complete clinical trials, obtain regulatory approvals, scale manufacturing, commercialize blood glucose sensors, and partner with device companies.